SCHEMBL7539666

SCHEMBL7539666

C1=NO1.Cc1ccc(C)c(OCC(C(=O)NN)c2ccccc2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.44
TSHR P16473 3/20 0.41
SMN1; SMN2 Q16637 3/20 0.41
MAPT P10636 2/20 0.41
USP2 O75604 2/20 0.41
ALOX15 P16050 1/20 0.41
HSD17B10 Q99714 1/20 0.41
SAE1 Q9UBE0 1/20 0.41
UBA2 Q9UBT2 1/20 0.41
CYP2C9 P11712 2/20 0.40
LMNA P02545 1/20 0.40
HTT P42858 1/20 0.40
KMT2A Q03164 4/20 0.39
MEN1 O00255 3/20 0.39
NPC1 O15118 1/20 0.39
RAB9A P51151 1/20 0.39
GAA P10253 1/20 0.38
KEAP1 Q14145 1/20 0.38
NFE2L2 Q16236 1/20 0.38
TDP1 Q9NUW8 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7543571 0.88 TSHR (0.46) TSHRSMN1; SMN2MAPTUSP2ALOX15
SCHEMBL7535615 0.87 SMN1; SMN2 (0.45) ALDH1A1TSHRSMN1; SMN2MAPTUSP2
SCHEMBL8193683 0.80 TSHR (0.52) ALDH1A1TSHRSMN1; SMN2USP2CYP2C9
SCHEMBL8200026 0.78 TSHR (0.50) ALDH1A1TSHRSMN1; SMN2USP2CYP2C9
SCHEMBL7540542 0.76 CYP2C9 (0.41) TSHRSMN1; SMN2MAPTUSP2ALOX15
SCHEMBL8197498 0.75 TSHR (0.46) TSHRSMN1; SMN2ALOX15CYP2C9LMNA
SCHEMBL7537858 0.75 SCN4A (0.39) ALDH1A1TSHRSMN1; SMN2MAPTUSP2
SCHEMBL27294428 0.71 TSHR (0.41) ALDH1A1TSHRSMN1; SMN2MAPTCYP2C9
SCHEMBL13950676 0.70 HTT (0.52) TSHRSMN1; SMN2ALOX15CYP2C9LMNA
SCHEMBL8347706 0.68 L3MBTL1 (0.52) ALDH1A1TSHRSMN1; SMN2MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6362212-B1 POTENT FUNGICIDAL ACTIVITY SHIONOGI & COMPANY, LTD. (JP) 2002-03-26 US disclosed
US-20020032227-A1 Oxime derivative and bactericide containing the same as active ingredient TAKASE AKIRA (JP) 2002-03-14 US disclosed
US-6268312-B1 FUNGICIDES SHIONOGI & CO., LTD. (JP) 2001-07-31 US disclosed
US-6048885-A FUNGICIDES SHIONOGI & CO., LTD. (JP) 2000-04-11 US disclosed
EP-0754684-A1 OXIME DERIVATIVE AND BACTERICIDE CONTAINING THE SAME AS ACTIVE INGREDIENT SHIONOGI & CO., LTD. (JP) 1997-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020032227-A1 Oxime derivative and bactericide containing the same as active ingredient MSMO1, O60361, CBR1 ALDH1A1 1113/4885TSHR 1672/4885SMN1; SMN2 2104/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.